MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 49 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,487,000 | +95.1% | 597,026 | +30.6% | 2.36% | +50.8% |
| Q2 2022 | $2,812,000 | +15.2% | 457,200 | +20.3% | 1.57% | +37.5% |
| Q1 2022 | $2,440,000 | -70.0% | 380,000 | -25.3% | 1.14% | -43.5% |
| Q4 2019 | $8,141,000 | +18.1% | 508,500 | +37.6% | 2.02% | -59.5% |
| Q3 2019 | $6,891,000 | -26.9% | 369,500 | +6.5% | 4.97% | +48.5% |
| Q2 2019 | $9,421,000 | – | 347,000 | – | 3.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |